About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $6.08B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Universal Beteiligungs Und Servicegesellschaft Mb H Portfolio

Follow Universal Beteiligungs Und Servicegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Universal Beteiligungs Und Servicegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Universal Beteiligungs Und Servicegesellschaft Mb H with notifications on news.